Varex Imaging Corporation
General ticker "VREX" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $461.1M (TTM average)
Varex Imaging Corporation follows the US Stock Market performance with the rate: 35.8%.
Estimated limits based on current volatility of 2.1%: low 11.41$, high 11.89$
Factors to consider:
- Total employees count: 2300 (-4.2%) as of 2024
- US accounted for 31.8% of revenue in the fiscal year ended 2024-09-27
- Top business risk factors: Dependency on oems, Market competition, Cybersecurity threats, Climate change and natural disasters, Geopolitical risks
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-09-30 to 2026-09-30
- 2024-09-30 to 2025-09-30 estimated range: [9.50$, 17.55$]
- 2025-09-30 to 2026-09-30 estimated range: [9.73$, 17.78$]
Financial Metrics affecting the VREX estimates:
- Positive: with PPE of 20.7 at the end of fiscal year the price was very low
- Positive: -3.60 < Operating profit margin, % of 3.96
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Positive: 6.82 < Operating cash flow per share per price, % of 10.17
- Negative: negative Industry operating income (median)
- Negative: Industry earnings per price (median), % of -5.56 <= 0
- Negative: Inventory ratio change, % of 1.75 > 0.84
Short-term VREX quotes
Long-term VREX plot with estimates
Financial data
| YTD | 2022-09-30 | 2023-09-30 | 2024-09-30 |
|---|---|---|---|
| Operating Revenue | $859.40MM | $893.40MM | $811.00MM |
| Operating Expenses | $771.20MM | $816.30MM | $778.90MM |
| Operating Income | $88.20MM | $77.10MM | $32.10MM |
| Non-Operating Income | $-43.70MM | $-45.80MM | $-27.10MM |
| Interest Expense | $39.80MM | $29.30MM | $31.10MM |
| R&D Expense | $77.00MM | $84.80MM | $87.00MM |
| Income(Loss) | $44.50MM | $31.30MM | $5.00MM |
| Taxes | $13.70MM | $-17.40MM | $52.20MM |
| Profit(Loss)* | $30.30MM | $48.20MM | $-47.70MM |
| Stockholders Equity | $533.40MM | $567.70MM | $535.10MM |
| Inventory | $303.20MM | $277.50MM | $264.80MM |
| Assets | $1,184.40MM | $1,249.60MM | $1,217.00MM |
| Operating Cash Flow | $16.90MM | $108.40MM | $47.30MM |
| Capital expenditure | $21.30MM | $20.70MM | $26.90MM |
| Investing Cash Flow | $-48.40MM | $-44.90MM | $-27.50MM |
| Financing Cash Flow | $-23.80MM | $-0.20MM | $-3.30MM |
| Earnings Per Share** | $0.76 | $1.20 | $-1.17 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.